Učitavanje...
Irreversible electroporation and the pancreas: What we know and where we are going?
Pancreatic adenocarcinoma continues to have a poor prognosis with 1 and 5 years survival rates of 27% and 6% respectively. The gold standard of treatment is resection, however, only approximately 10% of patients present with resectable disease. Approximately 40% of patients present with disease that...
Spremljeno u:
| Izdano u: | World J Gastrointest Surg |
|---|---|
| Glavni autor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Baishideng Publishing Group Inc
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4550840/ https://ncbi.nlm.nih.gov/pubmed/26328033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4240/wjgs.v7.i8.138 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|